These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30220705)

  • 21. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With Cancer.
    Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
    JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.
    Engelhardt EG; van den Broek AJ; Linn SC; Wishart GC; Rutgers EJT; van de Velde AO; Smit VTHBM; Voogd AC; Siesling S; Brinkhuis M; Seynaeve C; Westenend PJ; Stiggelbout AM; Tollenaar RAEM; van Leeuwen FE; van 't Veer LJ; Ravdin PM; Pharaoh PDP; Schmidt MK
    Eur J Cancer; 2017 Jun; 78():37-44. PubMed ID: 28412587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the performance of PREDICT tool in a large Mainland Chinese breast cancer cohort: a comparative analysis of versions 3.0 and 2.2.
    Chen E; Chen C; Chen Y; You J; Jin C; Huang Z; Zhang J; Wang Q; Cai Y; Hu X; Li Q
    Oncologist; 2024 Aug; 29(8):e976-e983. PubMed ID: 38943540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry.
    Kataoka A; Iwamoto T; Tokunaga E; Tomotaki A; Kumamaru H; Miyata H; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Kinoshita T; Nakamura S; Tokuda Y
    Breast Cancer Res Treat; 2016 Nov; 160(1):163-172. PubMed ID: 27647460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy.
    Grootes I; Wishart GC; Pharoah PDP
    NPJ Breast Cancer; 2024 Jan; 10(1):6. PubMed ID: 38225255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.
    Wu X; Ye Y; Barcenas CH; Chow WH; Meng QH; Chavez-MacGregor M; Hildebrandt MA; Zhao H; Gu X; Deng Y; Wagar E; Esteva FJ; Tripathy D; Hortobagyi GN
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in the survival of women with breast cancer in Scotland. The Scottish Breast Cancer Focus Group and The Scottish Cancer Therapy Network.
    Twelves CJ; Thomson CS; Gould A; Dewar JA
    Br J Cancer; 1998 Sep; 78(5):566-71. PubMed ID: 9744492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of myopia development among Chinese school-aged children using refraction data from electronic medical records: A retrospective, multicentre machine learning study.
    Lin H; Long E; Ding X; Diao H; Chen Z; Liu R; Huang J; Cai J; Xu S; Zhang X; Wang D; Chen K; Yu T; Wu D; Zhao X; Liu Z; Wu X; Jiang Y; Yang X; Cui D; Liu W; Zheng Y; Luo L; Wang H; Chan CC; Morgan IG; He M; Liu Y
    PLoS Med; 2018 Nov; 15(11):e1002674. PubMed ID: 30399150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.
    Maishman T; Copson E; Stanton L; Gerty S; Dicks E; Durcan L; Wishart GC; Pharoah P; ; Eccles D
    Br J Cancer; 2015 Mar; 112(6):983-91. PubMed ID: 25675148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin use and breast cancer survival: a nationwide cohort study in Scotland.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    BMC Cancer; 2016 Aug; 16():600. PubMed ID: 27491389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.
    Abdel-Qadir H; Austin PC; Lee DS; Amir E; Tu JV; Thavendiranathan P; Fung K; Anderson GM
    JAMA Cardiol; 2017 Jan; 2(1):88-93. PubMed ID: 27732702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A model building exercise of mortality risk for Taiwanese women with breast cancer.
    Chang TW; Kuo YL
    BMC Med Inform Decis Mak; 2010 Aug; 10():43. PubMed ID: 20723238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.
    Graesslin O; Abdulkarim BS; Coutant C; Huguet F; Gabos Z; Hsu L; Marpeau O; Uzan S; Pusztai L; Strom EA; Hortobagyi GN; Rouzier R; Ibrahim NK
    J Clin Oncol; 2010 Apr; 28(12):2032-7. PubMed ID: 20308667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.
    Cetin K; Christiansen CF; Sværke C; Jacobsen JB; Sørensen HT
    BMJ Open; 2015 Apr; 5(4):e007702. PubMed ID: 25926150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patients.
    Wen J; Yang Y; Liu P; Ye F; Tang H; Huang X; Zhong S; Xie X
    Breast; 2017 Jun; 33():14-22. PubMed ID: 28259045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival.
    Thomson CS; Hole DJ; Twelves CJ; Brewster DH; Black RJ;
    J Epidemiol Community Health; 2001 May; 55(5):308-15. PubMed ID: 11297648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External validation of a dynamic prediction model for repeated predictions of natural conception over time.
    van Eekelen R; McLernon DJ; van Wely M; Eijkemans MJ; Bhattacharya S; van der Veen F; van Geloven N
    Hum Reprod; 2018 Dec; 33(12):2268-2275. PubMed ID: 30358841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.
    Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Lindberg P; Gerstenhauer M; Schüler S; Treeck O; Ortmann O
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2229-40. PubMed ID: 26253629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.